Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Takara Bio Inc. ( (JP:4974) ) is now available.
Takara Bio Inc. will convene an extraordinary general meeting of shareholders on May 20, 2026, in Shiga Prefecture to vote on a share consolidation, abolition of the share unit provision, and partial amendments to its Articles of Incorporation. The moves follow a tender offer by parent Takara Holdings, which raised its stake to about 87.27 percent as part of a broader transaction aimed at taking Takara Bio private.
As a consequence of these steps, Takara Bio’s common shares will meet delisting criteria on the Tokyo Stock Exchange and are scheduled to be designated for delisting from May 20 through June 11, 2026, with official delisting on June 12, 2026. Afterward, the shares will no longer trade on the Prime Market, effectively completing the transition to a closely held structure and reducing liquidity and market access for remaining minority shareholders.
The most recent analyst rating on (JP:4974) stock is a Hold with a Yen940.00 price target. To see the full list of analyst forecasts on Takara Bio Inc. stock, see the JP:4974 Stock Forecast page.
More about Takara Bio Inc.
Takara Bio Inc., listed on the Tokyo Stock Exchange Prime section, operates in the biotechnology and life sciences industry. The company focuses on genomic and cell biology-related products and technologies, serving research, diagnostics, and therapeutic development markets under the umbrella of parent company Takara Holdings.
Average Trading Volume: 711,003
Technical Sentiment Signal: Sell
Current Market Cap: Yen137.6B
Learn more about 4974 stock on TipRanks’ Stock Analysis page.